CALGARY, Feb. 11 /CNW/ - SemBioSys Genetics Inc. (TSX: SBS), a
biotechnology company developing a portfolio of therapeutic proteins for
metabolic and cardiovascular diseases, today announced that Andrew Baum,
President and Chief Executive Officer of the Company, will be presenting a
corporate update at the 10th Annual BIO CEO & Investor Conference on
Wednesday, February 13, 2008 at the Waldorf Astoria Hotel in New York City.
Mr. Baum's presentation is scheduled at 3:30 P.M. ET in the Jade Room. A live
webcast of the presentation will be available by visiting the SemBioSys
homepage at www.sembiosys.com.
